Lake Street raised the firm’s price target on Sight Sciences (SGHT) to $3 from $2.50 and keeps a Hold rating on the shares. The firm, which believes Q1 highlights stabilization in the face of MIGS LCD pressures, continues to see potential for reacceleration in 2026 and thinks shares are likely trading near a trough multiple, but also believes broader payer progress on TearCare and normalized MIGS procedure volumes will be required to support growth acceleration.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGHT:
